The World Congress on Controversies in Neurology

Home
Welcome Note
Committees
Scientific Program
Timetable
Poster Presentations
General Information
Sponsors
Accompanying Persons’ Program
Past & Future CONy Congresses

 
The World Congress on Controversies in Neurology
The World Congress on Controversies in Neurology
 Sponsors   Registration   Accommodation   Contact 

 
Poster Presentations
 
Requirements
  • The poster board is 90 cm wide and 120 cm high (see image below).
  • On the top please indicate the title and author’s name as stated in the submitted abstract.
  • The text and illustrations should be readable from a distance of two meters (six feet).
  •  
    Posters are to be mounted on Thursday, September 6, 2007 from 12:00.
    Posters should be dismantled on Saturday, September 8, 2007 after 18:00 and will be the responsibility
    of the presenters. The Organizing Committee will not be responsible for posters that are not removed
    in time.
     
    Time of Presentation
    Poster presenters are kindly asked to be beside their posters during coffee breaks as follows:
    Group 1 – Friday, September 7, 2007.
    Group 2 – Saturday, September 8, 2007.
    Please check the list below for your board number and group.
    Tacks and technical equipment for the hanging of posters will be available.
     
    Sample of Poster:

     

    Poster Boards

    Board

     Title and Authors

    1

    SAFETY AND EFFICACY OF HIGH DOSES OF BOTOX IN THE TREATMENT OF CEREBRAL PALSY
    Y.M. Awaad, USA

    2

    DOES HEMORRHAGIC TRANSFORMATION OF CEREBRAL INFARCTION ALWAYS PREDICT UNFAVOURABLE OUTCOME?
    E. Batishcheva, N. Kuznetsov, O. Vinogradov, M. Gabotinskaya, Russia

    3

    LACUNAR AND NONLACUNAR STROKE OR TIA CAN BE DIFFERENTIATED IN THE ACUTE PHASE USING THE TRIAGE® STROKE PANEL
    R. Brouns, R. Sheorajpanday, P.P. De Deyn, Belgium

    4

    IMPAIRED DIASTOLIC FUNCTION IN YOUNG PATIENTS AFFECTED BY ISCHEMIC STROKE
    P. de Campora, L. Ragozzino, M. d'Ambrosio, A. Ascione, G. Di Micco, Italy

    5

    IMFLUENCE OF AGE ON VASCULAR RISK FACTORS PROFILE AMONG PATIENTS WITH STROKE AND TIA
    L. Castilla-Guerra, M.C. Fernández-Moreno, A. Espino-Montoro, J. Marín-Martín, J. Alvarez-Suero, E. Carmona-Nimo, F. Pozuelo-Del Rosal, J.M. López-Chozas, M.D. Jiménez-Hernández, Spain

    6

    VISUAL AGNOSIA IN ISCHEMIC STROKE–A RECOVERY PREDICTOR
    M. Deme, Germany

    7

    ANOSOGNOSIA IN ACUTE RIGHT HEMISPHERE STROKE, INFLUENCE ON THE PROGNOSIS
    S.M. Deme, C.D. Jianu, P.D. Nanu, S. Kory-Calomfirescu, Romania

    8

    SEASONAL VARIATION IN STROKE IN BMAKO, MALI
    D. Diallo, M.B Diarra, A. Diarra, M. Karambe, M.K. Toure, S. Traore, M. Sangare, M. Traore, Mali

    9

    ESSENTIAL TREMOR AND DEMENTIA – THE NEUROPATHOLOGICAL PATTERN
    P.G. Frisina, W. Tse, T.D. Halbig, L.S. Libow, USA

    10

    FOUR CASES OF SPONTANEOUS INTRACRANIAL HYPOTENSION ASSOCIATED WITH CHRONIC SUBDURAL HEMATOMAS
    K. Fujiwara, K. Saito, T. Ebina, Japan

    11

    SPONTANEOUS DISSECTION OF THE INTERNAL CAROTID ARTERIES AND RIGHT VERTEBRAL ARTERY IN A 17 YEAR OLD
    I. Geana, A. Nistorescu, A.M. Tataru, C. Horhoianu, S.G. Manda, V. Zamfir, Romania

    12

    HOMOCYSTEINEMIA WITH RECURRENT STROKE, EPILEPSY AND LIVEDO RETICULARIS: A CASE REPORT
    M. Ghabaee, A. Bayati, S. Assa, H. Sadeghian, Iran

    13

    RESTLESS LEGS SYNDROME IN CHRONIC HEMODIALYSIS PATIENTS: FREQUENCY, BIOCHEMICAL FINDINGS. IN SHIRAZ UNIVERSITY OF MEDICAL SCIENCE HOSPITAL IN SOUTHERN OF IRAN
    S. Gholamzadeh, M. Shakoor, Iran

    14

    POSTISCHEMIC INFLUENCE OF LESIONAL TOPOGRAPHY ON FUNCTIONAL DYNAMICS OF CORTICAL SENSORIMOTOR ACTIVATION
    V. Gonzalez-Felipe, R.J. Seitz, H. Freund, Germany

    15

    THE TIME DISCRIMINATION OF AUDITORY SYSTEM IN PERSONS WITH PARKINSON'S DISEASE
    E.J. Gorzelañczyk, J. Krolak, J. Zientalska, E. Laskowska, A. Stachowiak, A. Sêk, A. Wicher, Poland

    16

    CONTINUOUS DOPAMINERGIC STIMULATION IS A PROMISING THERAPEUTIC STRATEGY IN PARKINSON’S DISEASE
    R. Horowski, K.P. Latté, B. Schurad, H. Wachtel, D. Palla, F. Stocchi, Germany

    17

    TRANSIENT ISCAHEMIC ATTACK MANAGMENT SOFTWARE SYSTEM OR TIAM MANAGER
    A. Jafar, UK

    18

    THE PROTECTIVE EFFECT OF QUERCETIN IN AN EXPERIMENTAL MODEL OF PARKINSON DISEASE: A BEHAVIORAL AND HISTOCHEMICAL ANALYSIS IN ADULT RATS
    M.T. Joghataei, Iran

    19

    GENETIC POLYMORPHISM OF THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) IN PATIENTS WITH IDIOPATHIC PARKINSON’S DISEASE (IPD)
    W. Kim, K. Kim, H. Kim, Y. Koo, Korea

    20

    HEMISPHERE SPECIFIC CORRELATIONS BETWEEN EMOTIONAL-MNESTIC ACTIVITY AND SEPARATE BRAIN METABOLITE INDICES IN POST-ISCHEMIC STROKE PATIENTS
    V. Kuznetsov, Z. Rozhkova, D. Shulzhenko, E. Danich, Ukraine

    21

    BRAIN METABOLISM AND HEMODYNAMICS REORGANIZATION IN ELDERLY ISCHEMIC STROKE PATIENTS: HEMISPHERIC SPECIFICITIES
    S. Kuznetsova, Ukraine

    22

    THE ERGOLINE LISURIDE IS DEVOID OF 5-HT2B AGONISM AND LACKS CASE REPORTS OF VALVULAR HEART DISEASE
    K.P. Latté, B. Schurad, R. Horowski, Germany

    23

    FACTORS RELATED TO DEGREE OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE IN ACUTE STROKE PATIENTS
    J.H. Lee, Korea

    24

    SUBLIMINAL PRIMING EFFECT IN PATIENTS WITH PARKINSON’S DISEASE
    M. Michalak, P. Jaskowski, E.J. Gorzelañczyk, Poland

    25

    NEURO-SPIRITUALITY; A FUTURE HYPOTHETICAL ANS NOVEL APPROACH TO TREAT MEDICAL AND CNS CONDITIONS
    A. Moreira, USA

    26

    THREE CASES OF MULTIPLE SCLEROSIS ASOCIATED WITH POSITIVE RHEUMATOID ARTHRITIS FACTOR ANTIBODIES
    A. Moreira, USA

    27

    EFFECTS OF DIETARY/NUTRITIONAL INTERVENTIONS IN THE DEVELOPMENT OF RISK OF MULTIPLE SCLEROSIS
    S. Parekh, UK

    28

    THROMBOEMBOLIC PROPHYLAXIS IN PATIENTS WITH HYPERTENSIVE INTRACEREBRAL HEMATHOMA
    K. Popovic, S. Dunatov, A. Jurjevic, I. Antoncic, Croatia

    29

    PRIMARY WRITING TREMOR, TYPE B SEEN ONLY WHILE WRITTING NUMBERS AND NOT LETTERS OR SENTENCES
    A.Q. Rana, Canada

    30

    DO ISCHEMIC STROKE PATIENTS HAVE A TIGHTER FIBRIN NETWORK?
    E. Rooth, H. Wallen, M. Blombäck, S. He, Sweden

    31

    ASPECTS OF RETINAL VESSELS AND BRAIN ISCHEMIC LESSIONS ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODIES PRESENT
    T.I. Rosca, Romania

    32

    PECULIARITIES OF THE BRAIN METABOLISM IN NEONATES WITH CEREBRAL HYPOXIA-ISCHEMIA: MRI AND 1H MRS STUDY
    Z. Rozhkova, Ukraine

    33

    ASSESSMENT OF INTRACRANIAL STENOTIC ARTERIES IN DIABETIC PATIENTS OLDER THAN 50 YEARS WITH HYPERTENSION BY TRANSCRANIAL DOPPLER SONOGRAPHY AND DETERMINATION OF IT’S RISK FACTORS
    F. Sarvghadi,M. Karimi,F. Azizi, Iran

    34

    ISCHEMIC STROKE IN A PATIENT WITH TOURETTE´S SYNDROME: ASSOCIATION WITH THE ANTIPHOSPHOLIPID SYNDROME
    M. Seijo-Martinez, J.A. Mosquera-Martinez, S. Romero-Yuste, J. Cruz-Martinez, Spain

    35

    GENETIC POLYMORPHISM OF NQO1 ASSOCIATED WITH THE SUSCEPTIBILITY OF ISCHEMIC STROKE IN TAIWAN
    H. Shyu, C. Cheng, Taiwan R.O.C

    36

    LACUNAR STROKE: CASUAL HETEROGENITY
    O. Vinogradov, N. Kuznetsov, Russia

    37

    CENTRAL MOTOR CONDUCTION TIME COMPARED WITH UPPER MOTOR NEURON SIGNS AND MINIMAL VOLUNTARY CONTRACTION IN ALS PATIENTS USING TRANSCRANIAL MAGNETIC STIMULATION
    J. An, W. Kim, J. Kim, Y. Kim, K. Lee, B. Kim, S. Lee, Korea

    38

    COMPARISON OF SENSORY SYMPTOMS SCORE WITH NERVE CONDUCTION STUDY INCLUDING MEDIAL PLANTAR NERVE IN DIABETIC PATIENTS
    J. An, W. Kim, J. Kim, Y. Kim, K. Lee, B. Kim, Korea

    39

    BRAIN ABSCESS IN A 24-YEAR-OLD PATIENT WITH RENDU WEBER OSLER SYNDROME
    P. Angelidakis, V. Gourbali, M. Sakkopoulou, N. Matikas, Greece

    40

    ANAPHYLACTIC REACTION AFTER GADOLINIUM ADMINISTRATION DURING MRI IN PATIENT WITH PORPHYRIA
    E. Belniak, U. Chyrchel, K. Mitosek-Szewczyk, T. Stelmasiak, Z. Stelmasiak, Poland

    41

    RELATION BETWEEN IRON DEFICIENCY ANEMIA AND FIRST FEBRILE CONVULSION
    E. Bidabadi, M. Mashouf ,Iran

    42

    IMPAIRED MITOCHONDRIAL CALCIUM CAPACITY IN NEURONAL CELLS EXPRESSING SOD1 MUTANTS RELATED TO FAMILIAL ALS
    E. Cousse, E. Pille, E. Bogaert, I. Elens, W. Robberecht, L. Van Den Bosch, P. De Smet, G. Callewaert, Belgium

    43

    RELAPSE OF EPILEPSY OR PANIC DISORDER
    I. Filipcic, S. Basic, S. Hajnsek, Croatia

    44

    AN INVESTIGATION OF PULMONARY SILENT ASPIRATION AND PNEUMONIA IN ACUTE CARE SETTING IN SHIRAZ UNIVERSITY OF MEDICAL SCIENCE HOSPITALS, IRAN
    S. Gholamzadeh, M. Moattari, A. Emad, Iran

    45

    THE RELATIONSHIP BETWEEN EXECUTIVE AND MOTOR FUNCTIONING IN PATIENTS WITH PARKINSON'S DISEASE
    E.J. Gorzelanczyk, J. Jelonek, M. Olzak, Poland

    46

    ASSOCIATION OF A POLYMORPHISM IN MDR1 C3435T WITH RESPONSE TO ANTIEPILEPTIC DRUG TREATMENT IN CROATIAN PATIENTS WITH EPILEPSY
    S. Hajnsek, D. Sporis, N. Bozina, S. Basic, M. Lovric, I. Kovacevic, Croatia

    47

    VAGAL NERVE STIMULATION IN PATIENTS WITH REFRACTORY EPILEPSY AND POLYMICROGYRIA
    S. Hajnsek, S. Basic, D. Sporis, I. Filipcic, I. Kovacevic, Croatia

    48

    NEUTRALISING ANTIBODIES DID NOT AFFECT CLINICAL OUTCOMES AFTER 3 YEARS IN THE BENEFIT STUDIES
    H.P. Hartung, G. Edan, M.S. Freedman, L. Kappos, D.H. Miller, X. Montalban, C.H. Polman, L. Bauer, V. Lanius, C. Pohl, R. Sandbrink, UK

    49

    SCIATIC NERVE REGENERATION IN THE PIEZOELECTRIC TUBE: THE INFLUENCE OF NGF AND IGF-I
    M.T. Joghataei, T. Peirouvi, G.H. Farjah, M. Mehdizadeh, Iran

    50

    A GENETIC AND PHENOTYPIC STUDY OF A LARGE TURKISH FAMILY WITH SPINAL AND BULBAR MUSCULAR ATROPHY (KENNEDY’S DISEASE)
    H. Karaer, Y. Kaplan, S.G. Kurt, A. Gundogdu, B. Erdogan, A.N. Basak, Turkey

    51

    SOME INCONSISTENCIES IN DEFINITION AND CLASSIFICATION OF APHASIA
    V. Kljajevic, Canada

    52

    RISK OF COMPLICATIONS IN MIGRAINES WITH AURA (MA)
    D. Kountouris, K. Karachristou, A. Bougioukou, K. Koutsobelis, Greece

    53

    APALLIC SYNDROME (AS): A TABOO OF AN INCURABLE DISEASE AND CONSERVATISM IN MEDICINE
    B. Lushchyk, Ukraine

    54

    GOWERS INSULAR PANATROPHY- A BENIGN CONDITION?
    M. Macovei, C. Popa, A. Ilinca, Romania

    55

    MORPHOMETERIC STUDY OF PRIMARY SENSORY NEURONS FOLLOWING SURGICAL REPAIR OF SCIATIC NERVE
    M. Mehdizadeh, M.A. Atlasi, M.H. Bahadori, M.T. Joghataei, Iran

    56

    TRANSPLANTATION OF STEM CELLS IN NEUROLOGY
    N. Mironov, I. Saburina, D. Howe, N. Mkrtchyan, S. Ivanov, I. Mironov, Russia

    57

    CIGARETTE SMOKING-ALZHEIMER: AFTER 10 YEARS THE MYSTERY HAD BEEN SOLVED?
    A. Mititelu, UK

    58

    SLEEP DISORDERS IN LATE PREGNANCY AND EFFECTIVE FACTORS ON SLEEP DISORDERS AT THE LAST MONTH OF PREGNANCY IN FIRUZABADI HOSPITAL IN TEHRAN, 2006
    S. Nazarpour, M. Robatjazi, S.A. Siadati, Iran

    59

    FACTORS AFFECTING THE QUALITY OF LIFE IN CHRONIC EPILEPSY IN THAILAND
    K. Phabphal, K. Limapichat, P. Sathirapanya, S. Setthawatcharawanich, Thailand

    60

    THE POSTTRAUMATIC SURVIVAL OF DIFFERENT POPULATIONS DRG NEURONS BY ALLOTRANSPLANTATION OF FETAL TISSUES TO TRANSECTED SCIATIC NERVE IN THE RAT
    I. Raginov, G. Fomina, R. Masgutov, A. Malomug, M. Nigmetzyanova, Y. Chelyshev, Russia

    61

    INVESTIGATING THE EFFECT OF TENS ON PRIMARY DYSMENORRHEA IN THE STUDENTS OF TEHRAN MEDICAL SCIENCES UNIVERSITY RESIDENTIAL DORMITORY
    M. Robatjazi, S. Nazarpour, S.A. Siadati, Iran

    62

    DIFFERENTIATION OF OSTEOPOROSIS FROM OTHER VERTEBRAE PATHOLOGIES BASED ON MARROW FAT CONTENT: MRI AND 1H MRS STUDY
    Z. Rozhkova, D. Maksyuta, Ukraine

    63

    RECIDIVE POSTPARTAL CONVULSIONS - PRIMARY SEIZURE DISORDER OR POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
    J. Rudez, L. Antonelli, I. Antonèiæ, S. Dunatov, D. Cvjetoviæ, Croatia

    64

    TUMOR-LIKE MULTIPLE SCLEROSIS: A DIAGNOSTIC DILEMMA. REPORT OF 6 CASES
    M.G. Sakkopoulou, D. Karakalos, N. Matikas, Greece

    65

    ALZHEIMER'S CASES RECOVERY APPLYING A PROTOCOL DERIVED FROM THE CONTROVERSIAL PSYCHOSOCIAL THEORY
    L.M Sanchez, W. Pierce, J. Gomez Salgado, M.A. Leites, L.A. Portillo, E.D. Ferrari, G.A. Martinez, M.A. Jalife, M. Rubano, J.D. Garcia, Argentina

    66

    APOPTOTIC CHANGES IN THE CORTEX AND HIPPOCAMPUS OF MICE FOLLOWING MINIMAL BRAIN TRAUMA (MTBI)
    S. Schreiber, V. Tashlykov, Y. Katz, V. Gazit, O. Zohar, C.G. Pick, Israel

    67

    REVEALING THE DIAGNOSIS OF ALZHEIMER'S DISEASE: A TRANSVERSAL SURVEY OF BELGIAN NEUROLOGISTS AND NEUROPSYCHIATRISTS
    K. Segers, M. Meriem, C. Christian, Belgium

    68

    SUDDEN SMOKING CESSATION AND CHEMOSENSORY ABNORMALITIES ASSOCIATED WITH PATHOLOGIC HYPERSOMNIA WITH SLEEP APNEA
    H. Sienkiewicz-Jarosz, P. Bienkowski, P. Zatorski, A. Korkosz, A. Œciñska, D. Ryglewicz, Poland

    69

    THE EFFECT OF MODIFICATION OF PROPOFOL SPEED APPLICATION IN WADA TEST
    P. Soluch, O. Szymañska, A. Rysz, B. Majkowska-Zwoliñska, P. Kulisiewicz, A. Szczêsny, M. Jaworski, Poland

    70

    SOCIOMEDICAL ASPECTS OF EPILEPSY
    M. Sundaram Ramachandran, T.K. Subramanian Ponniah, India

    71

    MULTIPLE SCHWANNOMAS: SCHWANNOMATOSIS OR NEUROFIBROMATOSIS TYPE 2?
    M. Traore, J.T Thomas, M. Sangare, Mali

    72

    POSSIBILITIES OF INFLUENCING SOME ANTIEPILEPTIC BRAINSTEM SYSTEMS
    I. Verulashvili, Georgia
    73
    HUMAN CLAUSTRUM: A NEW DIVISION BASIS ON THE ANATOMICAL LANDMARKS AND MORPHOLOGICAL FINDINGS
    M.R. Namavar, Y. Sadeghi, H. Haghir, Iran
    74
    BOTULINUM TOXIN IN MULTIPLE SCLEROSIS - REHABILITATION UNIT EXPERIENCE
    E.A. Sevilla Hernandez,  J.V. Lozano Guadalajara  I. Martinez Gonzalez-Moro, Spain
    75
    BOTULINUM TOXIN IN FACIAL HEMISPASM - REHABILITATION UNIT EXPERIENCE
    E.A. Sevilla Hernandez,  J.V. Lozano Guadalajara  I. Martinez Gonzalez-Moro, Spain

     
    CREATED BY WEBSTUDIO   

    © All Rights Reserved 2006. Comtecmed.com